Advances in targeting of B-cell maturation antigen (BCMA) as an investigational novel therapeutic approach in multiple myeloma

Thursday, May 14, 2020
Time: 13:30
Virtual presentation


  • María -Victoria Mateos, MD, Ph.D., Associate Professor of Medicine, University of Salamanca (Salamanca, Spain)
  • Xavier LeLeu, MD, Ph.D., Professor, Head of the myeloma clinic and department of Haematology at Hôpital La Mileterie, Poitiers (Poitiers, France)


  • Highlight the unmet needs in the clinical management of RRMM
  • Examine BCMA as an ideal therapeutic target in RRMM
  • Explore novel investigational therapies and their therapeutic implications in the clinical management of RRMM
Welcome and Introductions
Dr. Leleu and Dr. Mateos
Challenging the current standard of care in RRMM
Dr. Leleu
BCMA: an ideal investigational therapeutic target in RRMM
Dr. Leleu
Current investigational approaches targeting BCMA
Dr. Mateos
Closing remarks
Dr. Leleu and Dr. Mateos